TrialJournal of Crohn's & colitis2023

Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes.

Fernando Magro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.